Having trouble accessing articles? Reset your cache.

July 17 Preclinical Quick Takes: Using CRISPR to edit TCRs, plus AAVs with synthetic promoters and AI for cancer diagnosis

CRISPR can modify TCRs to reprogram T cells
A Technical University Munich and Juno Therapeutics Inc. team led by TUM professor Dirk Busch used CRISPR to

Read the full 251 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE